FindTrial
Sign In

The influence of enhanced recovery after surgery (ERAS) on patients receiving lung cancer surgery: a retrospective study

The influence of enhanced recovery after surgery (ERAS) on patients receiving cancer surgery: a retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022478
Enrollment
Unknown
Registered
2019-04-13
Start date
2019-04-20
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

ERAS group and Non-ERAS group:No

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Analysis was performed between two time periods: Pre-ERAS (Enhanced recovery after surgery) (1/1/2012-12/31/2013), and implementation of ERAS (1/1/2015-12/31/2017), which we would like to compare the clinical outcomes between the two groups with or without ERAS pathway. The inclusive criteria were listed as follow: 1) diagnosed with primary non-small-cell lung cancer (NSCLC); 2) underwent VATS anatomical lung resection including lobectomy and segmentectomy; 3) age between 18-75 years old.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
the occurrence of postoperative pulmonary complications (PPCs);—

Secondary

MeasureTime frame
length of stay;in-hospital expense;—

Countries

China

Contacts

Public ContactGuowei Che

West China Hospital, Sichuan University

guowei_che@yahoo.com+86 28 85422494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026